Skip to main content

James F. Young, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Novavax Inc publishes a filing, an earnings call transcript or a press release.

Get NVAX alerts

About James F. Young, Ph.D.

James F. Young, Ph.D. is recorded as Board Member at Novavax Inc (NVAX) since June 16, 2022. Novavax Inc reported in an 8-K filed June 21, 2022 that James F. Young, Ph.D. was appointed Class III nominees for director, effective June 16, 2022. Novavax Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Novavax Inc includes John C. Jacobs (CEO and Board Member), James P. Kelly (CFO), John J. Trizzino (CFO and COO) and 7 others.

“Stockholders elected the following Class III nominees for director, each to serve a three-year term expiring at the 2025 Annual Meeting of Stockholders:”
Novavax Inc Form 8-K, filed June 21, 2022 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2022-06-16–present

Leadership on record at Novavax Inc

Recent activity